• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Comparing the incidence of lower extremity amputations across the world: the Global Lower Extremity Amputation Study.

出版信息

Diabet Med. 1995 Jan;12(1):14-8.

PMID:7712697
Abstract

A substantial proportion of lower extremity amputations (LEAs), particularly in people with diabetes, are thought to be preventable by the provision of appropriate health care. Information on the incidence of LEAs which is accurate, up-to-date, and comparable cross-sectionally and longitudinally is essential to guide and monitor interventions aimed at their prevention. Current information on the incidence of LEAs is limited and differences between studies in case definition, presentation of rates, level of ascertainment, and population age structure often make meaningful comparisons impossible. To remedy this situation the global LEA study has been established. The study is designed to compare the incidence of LEAs over time within and between communities across the world. The methodology includes adherence to a standard definition of LEA, standardized methods of data collection with built-in quality control, and correction for under-ascertainment of cases (using capture-recapture methodology). Centres wishing to take part in the study must be able to identify a study population of at least 250,000, have reasonably up-to-date population numbers by age and sex, and be prepared to stay in the study for at least 2 years. A study registration form (Appendix 1) is provided.

摘要

相似文献

1
Comparing the incidence of lower extremity amputations across the world: the Global Lower Extremity Amputation Study.
Diabet Med. 1995 Jan;12(1):14-8.
2
[Incidence of lower extremity amputations in diabetics].[糖尿病患者下肢截肢的发生率]
Pol Arch Med Wewn. 2001 Sep;106(3):829-38.
3
Lower extremity amputations among persons with diabetes mellitus--Washington, 1988.
MMWR Morb Mortal Wkly Rep. 1991 Nov 1;40(43):737-9.
4
The impact of diabetes-related lower-extremity amputations in The Netherlands.荷兰糖尿病相关下肢截肢的影响。
J Diabetes Complications. 1996 Nov-Dec;10(6):325-30. doi: 10.1016/1056-8727(95)00088-7.
5
Diabetes mellitus and nontraumatic lower extremity amputation in black and white Americans: the National Health and Nutrition Examination Survey Epidemiologic Follow-up Study, 1971-1992.美国黑人和白人中的糖尿病与非创伤性下肢截肢:1971 - 1992年国家健康和营养检查调查流行病学随访研究
Arch Intern Med. 1999 Nov 8;159(20):2470-5. doi: 10.1001/archinte.159.20.2470.
6
Trends in lower-extremity amputations in people with and without diabetes in Spain, 2001-2008.西班牙 2001-2008 年有和无糖尿病患者下肢截肢趋势。
Diabetes Care. 2011 Jul;34(7):1570-6. doi: 10.2337/dc11-0077. Epub 2011 May 18.
7
Diabetes- and nondiabetes-related lower extremity amputation incidence before and after the introduction of better organized diabetes foot care: continuous longitudinal monitoring using a standard method.采用标准方法进行连续纵向监测,观察在引入更有组织的糖尿病足护理前后,糖尿病相关和非糖尿病相关的下肢截肢发生率。
Diabetes Care. 2008 Mar;31(3):459-63. doi: 10.2337/dc07-1159. Epub 2007 Dec 10.
8
Capture-recapture method to estimate lower extremity amputation rates in Rio de Janeiro, Brazil.采用捕获-再捕获法估算巴西里约热内卢的下肢截肢率。
Rev Panam Salud Publica. 2001 Nov;10(5):334-40. doi: 10.1590/s1020-49892001001100007.
9
Diabetes and nontraumatic lower extremity amputations. Incidence, risk factors, and prevention--a 12-year follow-up study in Nauru.糖尿病与非创伤性下肢截肢。发病率、危险因素及预防——瑙鲁的一项12年随访研究
Diabetes Care. 1996 Jul;19(7):710-4. doi: 10.2337/diacare.19.7.710.
10
Explanations for the high risk of diabetes-related amputation in a Caribbean population of black african descent and potential for prevention.非洲裔加勒比人群中糖尿病相关截肢高风险的原因及预防可能性。
Diabetes Care. 2004 Nov;27(11):2636-41. doi: 10.2337/diacare.27.11.2636.

引用本文的文献

1
Clinical Outcomes of Ezetimibe Plus Statins in Patients With Lower Extremity Artery Disease.依折麦布联合他汀类药物治疗下肢动脉疾病患者的临床结局
JACC Adv. 2025 Aug 18;4(9):102074. doi: 10.1016/j.jacadv.2025.102074.
2
Relationship Between Neutrophil/Albumin Ratio and Early Mortality After Major Lower Extremity Amputation.中性粒细胞/白蛋白比值与下肢大截肢术后早期死亡率的关系
Cureus. 2021 Sep 5;13(9):e17733. doi: 10.7759/cureus.17733. eCollection 2021 Sep.
3
Major Lower Limb Amputations: Recognizing Pitfalls.主要下肢截肢术:识别陷阱。
Cureus. 2021 Aug 7;13(8):e16972. doi: 10.7759/cureus.16972. eCollection 2021 Aug.
4
Incidence and determinants of diabetes-related lower limb amputations in Ghana, 2010-2015- a retrospective cohort study.2010 - 2015年加纳糖尿病相关下肢截肢的发病率及影响因素——一项回顾性队列研究
BMC Endocr Disord. 2019 Mar 1;19(1):27. doi: 10.1186/s12902-019-0353-8.
5
Financial burden of diabetic foot ulcers to world: a progressive topic to discuss always.糖尿病足溃疡给全球带来的经济负担:一个始终值得探讨的不断发展的话题。
Ther Adv Endocrinol Metab. 2018 Jan;9(1):29-31. doi: 10.1177/2042018817744513. Epub 2017 Dec 12.
6
Clinical Characteristics and Risk Factor Analysis for Lower-Extremity Amputations in Diabetic Patients With Foot Ulcer Complicated by Necrotizing Fasciitis.糖尿病足溃疡合并坏死性筋膜炎患者下肢截肢的临床特征及危险因素分析
Medicine (Baltimore). 2015 Nov;94(44):e1957. doi: 10.1097/MD.0000000000001957.
7
Differences in the diagnosis and management of type 2 diabetes in 3 countries (US, UK, and Germany): results from a factorial experiment.3 个国家(美国、英国和德国)2 型糖尿病诊断和管理方面的差异:一项析因实验的结果。
Med Care. 2010 Apr;48(4):321-6. doi: 10.1097/mlr.0b013e3181ca3ffc.
8
Double blind, randomized, placebo controlled clinical trial for the treatment of diabetic foot ulcers, using a nitric oxide releasing patch: PATHON.使用一氧化氮释放贴片治疗糖尿病足溃疡的双盲、随机、安慰剂对照临床试验:PATHON。
Trials. 2007 Sep 26;8:26. doi: 10.1186/1745-6215-8-26.
9
[Incidence of amputaciones of the lower extremities in the population with diabetes mellitus in Málaga (1996-1997)].[马拉加糖尿病患者人群下肢截肢的发生率(1996 - 1997年)]
Aten Primaria. 2000 Dec;26(10):677-80. doi: 10.1016/s0212-6567(00)78750-6.
10
The cost of diabetic foot problems.糖尿病足问题的成本。
Pharmacoeconomics. 1995;8 Suppl 1:55-7. doi: 10.2165/00019053-199500081-00012.